📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Integrative viral genomics and bioinformatics platform

Lead Research Organisation: University of Glasgow
Department Name: UNLISTED

Abstract

Genome sequencing and associated computer-based analysis and methods have fundamentally transformed our understanding of viruses and the diseases they cause. The purpose of the integrative viral genomics and bioinformatics (iVGB) platform is to support CVR researchers and external collaborators across a range of virus-focused research projects, providing specialist expertise, resources and training to the wider UK and international virology community. The platform consists of the genomics and the bioinformatics teams, which work closely together. Uniquely in the UK, both teams are dedicated solely to virology and consist of experts in a wide range of topics relevant to the CVR research portfolio. Our research will be split into two overall objectives: (1) integration of genomic, evolutionary and phenotypic dimensions of viral infection (including the use of existing public data) in collaboration with the CVR research programmes and (2), with the Preparedness platform, response to outbreaks & enhanced surveillance

Technical Summary

The integrative viral genomics and bioinformatics (iVGB) platform aims to advance our understanding of viral diseases by developing and implementing sequencing procedures and bioinformatics analysis, applying them innovatively to virus-focused projects in collaboration with CVR researchers and partners.

There is an ongoing need to identify emerging and remerging viral threats, to monitor their evolution, including in the context of naïve and vaccinated populations, and to understand the mechanisms by which viruses exploit and disrupt cellular processes to cause disease. Viral genomics, host transcriptomics and associated bioinformatic approaches are transforming the tools available to tackle viruses, impacting basic understanding of infections, the development of antivirals and vaccines, and guiding public health actions.

Our bioinformatics and genomics researchers that comprise iVGB possess diverse expertise in sequencing and computational biology, including probe-based enrichment methods, multiplexed amplicon-based sequencing, metagenomics and various transcriptomics-associated approaches, and on the computational side expertise of viral and host genome evolution, epidemiology, sequence data analysis, comparative and structural virology, transcriptomics, integration of multi-omics data, statistics, machine learning, software engineering and web resource development.

Building on our current expertise, we have three objectives, which have a strong emphasis on adopting new technologies, improving existing ones applied to viruses, and providing expert know-how in computational tools. These are:
- To understand the genomic, evolutionary, spatial, temporal and phenotypic dimensions of infection, in collaboration with CVR research programmes and partners.
- To monitor and study viral outbreaks by performing sequence-based enhanced surveillance in collaboration with the CVR’s Preparedness platform.
- To share resources and expertise via one-to-one training and specialist courses with the wider UK and international virology community.

This research plan includes the application of viral genomics approaches to selected cohorts of patients and targeted environmental samples, in collaboration with the Virus Preparedness platform, while applying technologies focusing on infected cell/tissue omics in collaboration with the three core research programmes: Structure and function of virions, Host-cell responses to infection and Virus cross-species transmission.

iVGB is committed to advancing virus-focused research by leveraging cutting-edge sequencing procedures, bioinformatics analysis, and interdisciplinary collaborations, ultimately improving global health outcomes.

Publications

10 25 50

publication icon
Ashraf S (2023) EMERGING VIRUSES ARE AN UNDERESTIMATED CAUSE OF UNDIAGNOSED FEBRILE ILLNESS IN UGANDA in International Journal of Infectious Diseases

publication icon
Crits-Christoph A (2023) Genetic tracing of market wildlife and viruses at the epicenter of the COVID-19 pandemic. in bioRxiv : the preprint server for biology

 
Title Viro3D: a comprehensive database of virus protein structure predictions 
Description Combining two state-of-the-art approaches, AlphaFold2-ColabFold and ESMFold, we predicted models for 85,000 proteins from 4,400 human and animal viruses, expanding the structural coverage for viral proteins by 30 times compared to experimental structures. We also performed structural and network analyses of the models to demonstrate their utility for functional annotation and inference of distant phylogenetic relationships. 
Type Of Material Database/Collection of data 
Year Produced 2024 
Provided To Others? Yes  
Impact To enable further discoveries, we have created Viro3D (https://viro3d.cvr.gla.ac.uk/), a virus species-centred protein structure database. It allows users to search, browse and download protein models from a virus of interest and explore similar structures present in other virus species. This resource will facilitate fundamental molecular virology, investigation of virus evolution, and may enable structure-informed design of therapies and vaccines. 
URL https://viro3d.cvr.gla.ac.uk
 
Description In-house developed protocol for enhanced deployable virus detection 
Organisation The Wellcome Trust Sanger Institute
Country United Kingdom 
Sector Charity/Non Profit 
PI Contribution Developed a protocol that enables usage of comprehensive viral enrichment probes adapted to Oxford Nanopore Technologies (portable sequencer) in a multiplexed manner.
Collaborator Contribution Colleagues at the Respiratory Virus and Microbiome Initiative are currently assessing it in-house to evaluate deployment, efficiency and deployment
Impact Currently, meetings on going to discuss implementation
Start Year 2024
 
Description Member of G2P2 virology consortium 
Organisation Imperial College London
Country United Kingdom 
Sector Academic/University 
PI Contribution Characterisation and analysis of SARS-CoV-2 variants
Collaborator Contribution Keeping pace with SARS-CoV-2 variants, providing evidence to vaccine policy, and building agility for the next pandemic
Impact Papers and preprints on SARS-CoV-2 variants
Start Year 2023
 
Description Member of Mpox consortium 
Organisation The Pirbright Institute
Country United Kingdom 
Sector Academic/University 
PI Contribution Sequencing and bioinformatics analysis of mpox data
Collaborator Contribution Characterising the genome of the virus and studying how it is evolving, and how this is linked to changes in the transmission and pathology of the virus.
Impact Preprint to date
Start Year 2022
 
Description Member of influenza consortium, Flu: TrailMap-One Health 
Organisation Imperial College London
Country United Kingdom 
Sector Academic/University 
PI Contribution Bioinformatics contributing to development of a genome sequence resource
Collaborator Contribution Research linked to avian influenza spillover risk
Impact Preprints to date
Start Year 2024
 
Description AAV2 paeidtric hepatitis families event 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Patients, carers and/or patient groups
Results and Impact We contributed to an event to engage with children and their families who took part in the research led by the CVR on the finding of AAV2 in children with unexplained hepatitis. There were several outcomes in addition to the day long event itself; our main contribution was to the presentations on the day and to the resource pack entitled: Illness to Insight: A journey through participation in paediatric hepatitis research Audience: People/families who took part in this research study. Additionally, people/families who are being approached to be recruited into a research study. Purpose: To provide a slightly more detailed story about the public health response to the outbreak, the journey that the samples took through the research labs, and an explanation of what we understand about what happened to these children and why. This will also act as a case study for those who are being recruited in the future as it can give them a more detailed idea of what they might expect. We co-developed the section on the genomics and bioinformatics work involved in this research.
Year(s) Of Engagement Activity 2024
URL https://www.gla.ac.uk/news/archiveofnews/2023/march/headline_932485_en.html
 
Description Febrile Illness Guinea 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact To support implementation of a new sequenced-based technology in the lab and support capacity building. This is included presentations, lab work, and several customised sessions in-between the lab steps to explain them in detail. There was a high level of engagement with participants.
Year(s) Of Engagement Activity 2024
 
Description Kieran Lamb and Martha Luka recorded a video abstract 
Form Of Engagement Activity A broadcast e.g. TV/radio/film/podcast (other than news/press)
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact Video abstract titled 'Computational analysis reveals that our antiviral defences generate SARS-CoV-2 mutations' for paper: https://doi.org/10.1371/journal.pcbi.1011795
Year(s) Of Engagement Activity 2024
URL https://twitter.com/CVRinfo/status/1764977763750990179
 
Description Specialised training in viral genomics and bioinformatics 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Yearly, our team, in collaboration with colleagues from UCL, UK-HSA and Welcome Connect deliver a 6-day workshop to national and international participants aiming to receive training in clinical viral genomics and bioinformatics. The selection committee ensures that the 18 candidates selected every year, will be the ones that will benefit he most from this initiative, and offer bursaries to support some candidates.
Year(s) Of Engagement Activity 2025
URL https://coursesandconferences.wellcomeconnectingscience.org/event/genomics-and-clinical-virology-202...
 
Description Spyros Lytras created video abstract for publication 
Form Of Engagement Activity A broadcast e.g. TV/radio/film/podcast (other than news/press)
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact Video abstract titled 'Resurrecting an ancient bat defence against SARS-related coronaviruses' for paper: https://doi.org/10.1371/journal.pbio.3002398
Year(s) Of Engagement Activity 2023
URL https://twitter.com/CVRinfo